Prime Medicine
PRME
PRME
123 hedge funds and large institutions have $120M invested in Prime Medicine in 2025 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 41 increasing their positions, 36 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
26% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 27
36% less capital invested
Capital invested by funds: $188M → $120M (-$67.6M)
49% less call options, than puts
Call options by funds: $120K | Put options by funds: $237K
Holders
123
Holding in Top 10
1
Calls
$120K
Puts
$237K
Top Buyers
| 1 | +$891K | |
| 2 | +$453K | |
| 3 | +$329K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$275K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$210K |
Top Sellers
| 1 | -$4.09M | |
| 2 | -$2.58M | |
| 3 | -$2.1M | |
| 4 |
Walleye Capital
New York
|
-$1.18M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$632K |